These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3913976)

  • 1. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. II. Comparison of the effects of various thymoleptics on the psychopathological symptoms of endogenous depressive syndromes].
    Strzyzewski W; Twarowska-Hauser J; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E
    Psychiatr Pol; 1985; 19(5):363-9. PubMed ID: 3913976
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. I. Analysis of the clinical effect of antidepressive drugs with various pharmacological profiles].
    Twarowska-Hauser J; Strzyzewksi W; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E
    Psychiatr Pol; 1985; 19(5):357-62. PubMed ID: 3913975
    [No Abstract]   [Full Text] [Related]  

  • 3. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. III. Analysis of the factors affecting the effectiveness of treatment with thymoleptics].
    Twarowska-Hauser J; Strzyzewski W
    Psychiatr Pol; 1985; 19(5):370-5. PubMed ID: 3913977
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical characteristics and typological classification of endogenous depression resistant to treatment].
    Bondar' VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):84-8. PubMed ID: 1319660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
    Giner Ubago J; González Infante JM; Blanco Picabia A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):73-80. PubMed ID: 6372376
    [No Abstract]   [Full Text] [Related]  

  • 6. Lithium treatment of depression.
    Noyes R; Dempsey GM
    Dis Nerv Syst; 1974 Dec; 35(12):573-6. PubMed ID: 17896758
    [No Abstract]   [Full Text] [Related]  

  • 7. On being bipolar without being bipolar.
    Goldberg J
    J Psychopharmacol; 2008 Jun; 22(4):402-3; discussion 408. PubMed ID: 18635717
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of clinical, psychophysiological and biological factors in the therapeutic effectiveness of antidepressive agents].
    Strzyzewski W
    Psychiatr Pol; 1986; 20(6):428-35. PubMed ID: 3602202
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of lithium to augment antidepressant medication.
    Rouillon F; Gorwood P
    J Clin Psychiatry; 1998; 59 Suppl 5():32-9; discussion 40-1. PubMed ID: 9635546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bipolar depression: specific treatments.
    Potter WZ
    J Clin Psychiatry; 1998; 59 Suppl 18():30-6. PubMed ID: 9840196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the best approach to management of acute depression in bipolar disorder?
    Joffe RT; MacQueen GM; Young LT
    J Psychiatry Neurosci; 2000 Nov; 25(5):516. PubMed ID: 11109302
    [No Abstract]   [Full Text] [Related]  

  • 12. Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk.
    O'Donovan C; Garnham JS; Hajek T; Alda M
    J Affect Disord; 2008 Apr; 107(1-3):293-8. PubMed ID: 17850879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical criteria for choosing an antidepressive drug].
    Manus A
    Encephale; 1995 Dec; 21 Spec No 4():19-21. PubMed ID: 8808341
    [No Abstract]   [Full Text] [Related]  

  • 14. [GABA levels in the plasma of patients with endogenous depression and during the treatment with thymoleptics].
    Rode A; Bidziński A; Puzyński S
    Psychiatr Pol; 1991; 25(3-4):4-7. PubMed ID: 1821976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exacerbation of an affective psychosis after terminating a decade of benzodiazepine treatment. Which therapeutic procedure is sensible?].
    Soyka M; Lehle R; Hippius H
    Nervenarzt; 1994 Sep; 65(9):628-32. PubMed ID: 7991010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modern pharmacopoeia: a return to depressive realism?
    Goldberg JF
    Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
    [No Abstract]   [Full Text] [Related]  

  • 17. Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients.
    Jensen JE; Daniels M; Haws C; Bolo NR; Lyoo IK; Yoon SJ; Cohen BM; Stoll AL; Rusche JR; Renshaw PF
    Exp Clin Psychopharmacol; 2008 Jun; 16(3):199-206. PubMed ID: 18540779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of the seasons on the course and therapeutic results of depressive phases of maniomelancholy (author's transl)].
    Sedivec V
    Cesk Psychiatr; 1981 Oct; 77(5):326-30. PubMed ID: 7326778
    [No Abstract]   [Full Text] [Related]  

  • 19. Upping the ante on antidepressants.
    Malhi GS
    Bipolar Disord; 2008 Dec; 10(8):975-8. PubMed ID: 19594513
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute effects of the synthetic analogue of methionine enkephalin FK 33-824 on depressive symptoms.
    Jungkunz G; Nedopil N; Rüther E
    Pharmacopsychiatria; 1983 May; 16(3):90-2. PubMed ID: 6351118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.